Global T Cell Specific Surface Glycoprotein CD28 Market Growth 2025-2031

October 2025 | 81 pages | ID: G107C94E6317EN
LP Information

Abstracts

The global T Cell Specific Surface Glycoprotein CD28 market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

United States market for T Cell Specific Surface Glycoprotein CD28 is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for T Cell Specific Surface Glycoprotein CD28 is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for T Cell Specific Surface Glycoprotein CD28 is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key T Cell Specific Surface Glycoprotein CD28 players cover Atox Bio Ltd, Bristol-Myers Squibb Co, Five Prime Therapeutics Inc, Johnson & Johnson, TheraMAB LLC, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the ?T Cell Specific Surface Glycoprotein CD28 Industry Forecast? looks at past sales and reviews total world T Cell Specific Surface Glycoprotein CD28 sales in 2024, providing a comprehensive analysis by region and market sector of projected T Cell Specific Surface Glycoprotein CD28 sales for 2025 through 2031. With T Cell Specific Surface Glycoprotein CD28 sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world T Cell Specific Surface Glycoprotein CD28 industry.

This Insight Report provides a comprehensive analysis of the global T Cell Specific Surface Glycoprotein CD28 landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on T Cell Specific Surface Glycoprotein CD28 portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global T Cell Specific Surface Glycoprotein CD28 market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for T Cell Specific Surface Glycoprotein CD28 and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global T Cell Specific Surface Glycoprotein CD28.

This report presents a comprehensive overview, market shares, and growth opportunities of T Cell Specific Surface Glycoprotein CD28 market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• FPT-155
• FR-104
• Lulizumab Pegol
• Others

Segmentation by Application:

• Plaque Psoriasis
• Solid Tumor
• Acute Renal Failure(ARF)
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Atox Bio Ltd
• Bristol-Myers Squibb Co
• Five Prime Therapeutics Inc
• Johnson & Johnson
• TheraMAB LLC

Key Questions Addressed in this Report

What is the 10-year outlook for the global T Cell Specific Surface Glycoprotein CD28 market?
What factors are driving T Cell Specific Surface Glycoprotein CD28 market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do T Cell Specific Surface Glycoprotein CD28 market opportunities vary by end market size?
How does T Cell Specific Surface Glycoprotein CD28 break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global T Cell Specific Surface Glycoprotein CD28 Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for T Cell Specific Surface Glycoprotein CD28 by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for T Cell Specific Surface Glycoprotein CD28 by Country/Region, 2020, 2024 & 2031
2.2 T Cell Specific Surface Glycoprotein CD28 Segment by Type
  2.2.1 FPT-155
  2.2.2 FR-104
  2.2.3 Lulizumab Pegol
  2.2.4 Others
2.3 T Cell Specific Surface Glycoprotein CD28 Sales by Type
  2.3.1 Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Type (2020-2025)
  2.3.2 Global T Cell Specific Surface Glycoprotein CD28 Revenue and Market Share by Type (2020-2025)
  2.3.3 Global T Cell Specific Surface Glycoprotein CD28 Sale Price by Type (2020-2025)
2.4 T Cell Specific Surface Glycoprotein CD28 Segment by Application
  2.4.1 Plaque Psoriasis
  2.4.2 Solid Tumor
  2.4.3 Acute Renal Failure(ARF)
  2.4.4 Others
2.5 T Cell Specific Surface Glycoprotein CD28 Sales by Application
  2.5.1 Global T Cell Specific Surface Glycoprotein CD28 Sale Market Share by Application (2020-2025)
  2.5.2 Global T Cell Specific Surface Glycoprotein CD28 Revenue and Market Share by Application (2020-2025)
  2.5.3 Global T Cell Specific Surface Glycoprotein CD28 Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global T Cell Specific Surface Glycoprotein CD28 Breakdown Data by Company
  3.1.1 Global T Cell Specific Surface Glycoprotein CD28 Annual Sales by Company (2020-2025)
  3.1.2 Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Company (2020-2025)
3.2 Global T Cell Specific Surface Glycoprotein CD28 Annual Revenue by Company (2020-2025)
  3.2.1 Global T Cell Specific Surface Glycoprotein CD28 Revenue by Company (2020-2025)
  3.2.2 Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Company (2020-2025)
3.3 Global T Cell Specific Surface Glycoprotein CD28 Sale Price by Company
3.4 Key Manufacturers T Cell Specific Surface Glycoprotein CD28 Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers T Cell Specific Surface Glycoprotein CD28 Product Location Distribution
  3.4.2 Players T Cell Specific Surface Glycoprotein CD28 Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR T CELL SPECIFIC SURFACE GLYCOPROTEIN CD28 BY GEOGRAPHIC REGION

4.1 World Historic T Cell Specific Surface Glycoprotein CD28 Market Size by Geographic Region (2020-2025)
  4.1.1 Global T Cell Specific Surface Glycoprotein CD28 Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global T Cell Specific Surface Glycoprotein CD28 Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic T Cell Specific Surface Glycoprotein CD28 Market Size by Country/Region (2020-2025)
  4.2.1 Global T Cell Specific Surface Glycoprotein CD28 Annual Sales by Country/Region (2020-2025)
  4.2.2 Global T Cell Specific Surface Glycoprotein CD28 Annual Revenue by Country/Region (2020-2025)
4.3 Americas T Cell Specific Surface Glycoprotein CD28 Sales Growth
4.4 APAC T Cell Specific Surface Glycoprotein CD28 Sales Growth
4.5 Europe T Cell Specific Surface Glycoprotein CD28 Sales Growth
4.6 Middle East & Africa T Cell Specific Surface Glycoprotein CD28 Sales Growth

5 AMERICAS

5.1 Americas T Cell Specific Surface Glycoprotein CD28 Sales by Country
  5.1.1 Americas T Cell Specific Surface Glycoprotein CD28 Sales by Country (2020-2025)
  5.1.2 Americas T Cell Specific Surface Glycoprotein CD28 Revenue by Country (2020-2025)
5.2 Americas T Cell Specific Surface Glycoprotein CD28 Sales by Type (2020-2025)
5.3 Americas T Cell Specific Surface Glycoprotein CD28 Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC T Cell Specific Surface Glycoprotein CD28 Sales by Region
  6.1.1 APAC T Cell Specific Surface Glycoprotein CD28 Sales by Region (2020-2025)
  6.1.2 APAC T Cell Specific Surface Glycoprotein CD28 Revenue by Region (2020-2025)
6.2 APAC T Cell Specific Surface Glycoprotein CD28 Sales by Type (2020-2025)
6.3 APAC T Cell Specific Surface Glycoprotein CD28 Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe T Cell Specific Surface Glycoprotein CD28 by Country
  7.1.1 Europe T Cell Specific Surface Glycoprotein CD28 Sales by Country (2020-2025)
  7.1.2 Europe T Cell Specific Surface Glycoprotein CD28 Revenue by Country (2020-2025)
7.2 Europe T Cell Specific Surface Glycoprotein CD28 Sales by Type (2020-2025)
7.3 Europe T Cell Specific Surface Glycoprotein CD28 Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa T Cell Specific Surface Glycoprotein CD28 by Country
  8.1.1 Middle East & Africa T Cell Specific Surface Glycoprotein CD28 Sales by Country (2020-2025)
  8.1.2 Middle East & Africa T Cell Specific Surface Glycoprotein CD28 Revenue by Country (2020-2025)
8.2 Middle East & Africa T Cell Specific Surface Glycoprotein CD28 Sales by Type (2020-2025)
8.3 Middle East & Africa T Cell Specific Surface Glycoprotein CD28 Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of T Cell Specific Surface Glycoprotein CD28
10.3 Manufacturing Process Analysis of T Cell Specific Surface Glycoprotein CD28
10.4 Industry Chain Structure of T Cell Specific Surface Glycoprotein CD28

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 T Cell Specific Surface Glycoprotein CD28 Distributors
11.3 T Cell Specific Surface Glycoprotein CD28 Customer

12 WORLD FORECAST REVIEW FOR T CELL SPECIFIC SURFACE GLYCOPROTEIN CD28 BY GEOGRAPHIC REGION

12.1 Global T Cell Specific Surface Glycoprotein CD28 Market Size Forecast by Region
  12.1.1 Global T Cell Specific Surface Glycoprotein CD28 Forecast by Region (2026-2031)
  12.1.2 Global T Cell Specific Surface Glycoprotein CD28 Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global T Cell Specific Surface Glycoprotein CD28 Forecast by Type (2026-2031)
12.7 Global T Cell Specific Surface Glycoprotein CD28 Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Atox Bio Ltd
  13.1.1 Atox Bio Ltd Company Information
  13.1.2 Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 Product Portfolios and Specifications
  13.1.3 Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Atox Bio Ltd Main Business Overview
  13.1.5 Atox Bio Ltd Latest Developments
13.2 Bristol-Myers Squibb Co
  13.2.1 Bristol-Myers Squibb Co Company Information
  13.2.2 Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 Product Portfolios and Specifications
  13.2.3 Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Bristol-Myers Squibb Co Main Business Overview
  13.2.5 Bristol-Myers Squibb Co Latest Developments
13.3 Five Prime Therapeutics Inc
  13.3.1 Five Prime Therapeutics Inc Company Information
  13.3.2 Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 Product Portfolios and Specifications
  13.3.3 Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Five Prime Therapeutics Inc Main Business Overview
  13.3.5 Five Prime Therapeutics Inc Latest Developments
13.4 Johnson & Johnson
  13.4.1 Johnson & Johnson Company Information
  13.4.2 Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 Product Portfolios and Specifications
  13.4.3 Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Johnson & Johnson Main Business Overview
  13.4.5 Johnson & Johnson Latest Developments
13.5 TheraMAB LLC
  13.5.1 TheraMAB LLC Company Information
  13.5.2 TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 Product Portfolios and Specifications
  13.5.3 TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 TheraMAB LLC Main Business Overview
  13.5.5 TheraMAB LLC Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. T Cell Specific Surface Glycoprotein CD28 Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. T Cell Specific Surface Glycoprotein CD28 Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of FPT-155
Table 4. Major Players of FR-104
Table 5. Major Players of Lulizumab Pegol
Table 6. Major Players of Others
Table 7. Global T Cell Specific Surface Glycoprotein CD28 Sales by Type (2020-2025) & (K Pcs)
Table 8. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Type (2020-2025)
Table 9. Global T Cell Specific Surface Glycoprotein CD28 Revenue by Type (2020-2025) & ($ million)
Table 10. Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Type (2020-2025)
Table 11. Global T Cell Specific Surface Glycoprotein CD28 Sale Price by Type (2020-2025) & (USD/Pcs)
Table 12. Global T Cell Specific Surface Glycoprotein CD28 Sale by Application (2020-2025) & (K Pcs)
Table 13. Global T Cell Specific Surface Glycoprotein CD28 Sale Market Share by Application (2020-2025)
Table 14. Global T Cell Specific Surface Glycoprotein CD28 Revenue by Application (2020-2025) & ($ million)
Table 15. Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Application (2020-2025)
Table 16. Global T Cell Specific Surface Glycoprotein CD28 Sale Price by Application (2020-2025) & (USD/Pcs)
Table 17. Global T Cell Specific Surface Glycoprotein CD28 Sales by Company (2020-2025) & (K Pcs)
Table 18. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Company (2020-2025)
Table 19. Global T Cell Specific Surface Glycoprotein CD28 Revenue by Company (2020-2025) & ($ millions)
Table 20. Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Company (2020-2025)
Table 21. Global T Cell Specific Surface Glycoprotein CD28 Sale Price by Company (2020-2025) & (USD/Pcs)
Table 22. Key Manufacturers T Cell Specific Surface Glycoprotein CD28 Producing Area Distribution and Sales Area
Table 23. Players T Cell Specific Surface Glycoprotein CD28 Products Offered
Table 24. T Cell Specific Surface Glycoprotein CD28 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global T Cell Specific Surface Glycoprotein CD28 Sales by Geographic Region (2020-2025) & (K Pcs)
Table 28. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share Geographic Region (2020-2025)
Table 29. Global T Cell Specific Surface Glycoprotein CD28 Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global T Cell Specific Surface Glycoprotein CD28 Sales by Country/Region (2020-2025) & (K Pcs)
Table 32. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Country/Region (2020-2025)
Table 33. Global T Cell Specific Surface Glycoprotein CD28 Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas T Cell Specific Surface Glycoprotein CD28 Sales by Country (2020-2025) & (K Pcs)
Table 36. Americas T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Country (2020-2025)
Table 37. Americas T Cell Specific Surface Glycoprotein CD28 Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas T Cell Specific Surface Glycoprotein CD28 Sales by Type (2020-2025) & (K Pcs)
Table 39. Americas T Cell Specific Surface Glycoprotein CD28 Sales by Application (2020-2025) & (K Pcs)
Table 40. APAC T Cell Specific Surface Glycoprotein CD28 Sales by Region (2020-2025) & (K Pcs)
Table 41. APAC T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Region (2020-2025)
Table 42. APAC T Cell Specific Surface Glycoprotein CD28 Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC T Cell Specific Surface Glycoprotein CD28 Sales by Type (2020-2025) & (K Pcs)
Table 44. APAC T Cell Specific Surface Glycoprotein CD28 Sales by Application (2020-2025) & (K Pcs)
Table 45. Europe T Cell Specific Surface Glycoprotein CD28 Sales by Country (2020-2025) & (K Pcs)
Table 46. Europe T Cell Specific Surface Glycoprotein CD28 Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe T Cell Specific Surface Glycoprotein CD28 Sales by Type (2020-2025) & (K Pcs)
Table 48. Europe T Cell Specific Surface Glycoprotein CD28 Sales by Application (2020-2025) & (K Pcs)
Table 49. Middle East & Africa T Cell Specific Surface Glycoprotein CD28 Sales by Country (2020-2025) & (K Pcs)
Table 50. Middle East & Africa T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa T Cell Specific Surface Glycoprotein CD28 Sales by Type (2020-2025) & (K Pcs)
Table 52. Middle East & Africa T Cell Specific Surface Glycoprotein CD28 Sales by Application (2020-2025) & (K Pcs)
Table 53. Key Market Drivers & Growth Opportunities of T Cell Specific Surface Glycoprotein CD28
Table 54. Key Market Challenges & Risks of T Cell Specific Surface Glycoprotein CD28
Table 55. Key Industry Trends of T Cell Specific Surface Glycoprotein CD28
Table 56. T Cell Specific Surface Glycoprotein CD28 Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. T Cell Specific Surface Glycoprotein CD28 Distributors List
Table 59. T Cell Specific Surface Glycoprotein CD28 Customer List
Table 60. Global T Cell Specific Surface Glycoprotein CD28 Sales Forecast by Region (2026-2031) & (K Pcs)
Table 61. Global T Cell Specific Surface Glycoprotein CD28 Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas T Cell Specific Surface Glycoprotein CD28 Sales Forecast by Country (2026-2031) & (K Pcs)
Table 63. Americas T Cell Specific Surface Glycoprotein CD28 Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC T Cell Specific Surface Glycoprotein CD28 Sales Forecast by Region (2026-2031) & (K Pcs)
Table 65. APAC T Cell Specific Surface Glycoprotein CD28 Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe T Cell Specific Surface Glycoprotein CD28 Sales Forecast by Country (2026-2031) & (K Pcs)
Table 67. Europe T Cell Specific Surface Glycoprotein CD28 Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa T Cell Specific Surface Glycoprotein CD28 Sales Forecast by Country (2026-2031) & (K Pcs)
Table 69. Middle East & Africa T Cell Specific Surface Glycoprotein CD28 Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global T Cell Specific Surface Glycoprotein CD28 Sales Forecast by Type (2026-2031) & (K Pcs)
Table 71. Global T Cell Specific Surface Glycoprotein CD28 Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global T Cell Specific Surface Glycoprotein CD28 Sales Forecast by Application (2026-2031) & (K Pcs)
Table 73. Global T Cell Specific Surface Glycoprotein CD28 Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. Atox Bio Ltd Basic Information, T Cell Specific Surface Glycoprotein CD28 Manufacturing Base, Sales Area and Its Competitors
Table 75. Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 Product Portfolios and Specifications
Table 76. Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 77. Atox Bio Ltd Main Business
Table 78. Atox Bio Ltd Latest Developments
Table 79. Bristol-Myers Squibb Co Basic Information, T Cell Specific Surface Glycoprotein CD28 Manufacturing Base, Sales Area and Its Competitors
Table 80. Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 Product Portfolios and Specifications
Table 81. Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 82. Bristol-Myers Squibb Co Main Business
Table 83. Bristol-Myers Squibb Co Latest Developments
Table 84. Five Prime Therapeutics Inc Basic Information, T Cell Specific Surface Glycoprotein CD28 Manufacturing Base, Sales Area and Its Competitors
Table 85. Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 Product Portfolios and Specifications
Table 86. Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 87. Five Prime Therapeutics Inc Main Business
Table 88. Five Prime Therapeutics Inc Latest Developments
Table 89. Johnson & Johnson Basic Information, T Cell Specific Surface Glycoprotein CD28 Manufacturing Base, Sales Area and Its Competitors
Table 90. Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 Product Portfolios and Specifications
Table 91. Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 92. Johnson & Johnson Main Business
Table 93. Johnson & Johnson Latest Developments
Table 94. TheraMAB LLC Basic Information, T Cell Specific Surface Glycoprotein CD28 Manufacturing Base, Sales Area and Its Competitors
Table 95. TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 Product Portfolios and Specifications
Table 96. TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 97. TheraMAB LLC Main Business
Table 98. TheraMAB LLC Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of T Cell Specific Surface Glycoprotein CD28
Figure 2. T Cell Specific Surface Glycoprotein CD28 Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global T Cell Specific Surface Glycoprotein CD28 Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global T Cell Specific Surface Glycoprotein CD28 Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. T Cell Specific Surface Glycoprotein CD28 Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Country/Region (2024)
Figure 10. T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of FPT-155
Figure 12. Product Picture of FR-104
Figure 13. Product Picture of Lulizumab Pegol
Figure 14. Product Picture of Others
Figure 15. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Type in 2025
Figure 16. Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Type (2020-2025)
Figure 17. T Cell Specific Surface Glycoprotein CD28 Consumed in Plaque Psoriasis
Figure 18. Global T Cell Specific Surface Glycoprotein CD28 Market: Plaque Psoriasis (2020-2025) & (K Pcs)
Figure 19. T Cell Specific Surface Glycoprotein CD28 Consumed in Solid Tumor
Figure 20. Global T Cell Specific Surface Glycoprotein CD28 Market: Solid Tumor (2020-2025) & (K Pcs)
Figure 21. T Cell Specific Surface Glycoprotein CD28 Consumed in Acute Renal Failure(ARF)
Figure 22. Global T Cell Specific Surface Glycoprotein CD28 Market: Acute Renal Failure(ARF) (2020-2025) & (K Pcs)
Figure 23. T Cell Specific Surface Glycoprotein CD28 Consumed in Others
Figure 24. Global T Cell Specific Surface Glycoprotein CD28 Market: Others (2020-2025) & (K Pcs)
Figure 25. Global T Cell Specific Surface Glycoprotein CD28 Sale Market Share by Application (2024)
Figure 26. Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Application in 2025
Figure 27. T Cell Specific Surface Glycoprotein CD28 Sales by Company in 2025 (K Pcs)
Figure 28. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Company in 2025
Figure 29. T Cell Specific Surface Glycoprotein CD28 Revenue by Company in 2025 ($ millions)
Figure 30. Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Company in 2025
Figure 31. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Geographic Region (2020-2025)
Figure 32. Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Geographic Region in 2025
Figure 33. Americas T Cell Specific Surface Glycoprotein CD28 Sales 2020-2025 (K Pcs)
Figure 34. Americas T Cell Specific Surface Glycoprotein CD28 Revenue 2020-2025 ($ millions)
Figure 35. APAC T Cell Specific Surface Glycoprotein CD28 Sales 2020-2025 (K Pcs)
Figure 36. APAC T Cell Specific Surface Glycoprotein CD28 Revenue 2020-2025 ($ millions)
Figure 37. Europe T Cell Specific Surface Glycoprotein CD28 Sales 2020-2025 (K Pcs)
Figure 38. Europe T Cell Specific Surface Glycoprotein CD28 Revenue 2020-2025 ($ millions)
Figure 39. Middle East & Africa T Cell Specific Surface Glycoprotein CD28 Sales 2020-2025 (K Pcs)
Figure 40. Middle East & Africa T Cell Specific Surface Glycoprotein CD28 Revenue 2020-2025 ($ millions)
Figure 41. Americas T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Country in 2025
Figure 42. Americas T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Country (2020-2025)
Figure 43. Americas T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Type (2020-2025)
Figure 44. Americas T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Application (2020-2025)
Figure 45. United States T Cell Specific Surface Glycoprotein CD28 Revenue Growth 2020-2025 ($ millions)
Figure 46. Canada T Cell Specific Surface Glycoprotein CD28 Revenue Growth 2020-2025 ($ millions)
Figure 47. Mexico T Cell Specific Surface Glycoprotein CD28 Revenue Growth 2020-2025 ($ millions)
Figure 48. Brazil T Cell Specific Surface Glycoprotein CD28 Revenue Growth 2020-2025 ($ millions)
Figure 49. APAC T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Region in 2025
Figure 50. APAC T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Region (2020-2025)
Figure 51. APAC T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Type (2020-2025)
Figure 52. APAC T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Application (2020-2025)
Figure 53. China T Cell Specific Surface Glycoprotein CD28 Revenue Growth 2020-2025 ($ millions)
Figure 54. Japan T Cell Specific Surface Glycoprotein CD28 Revenue Growth 2020-2025 ($ millions)
Figure 55. South Korea T Cell Specific Surface Glycoprotein CD28 Revenue Growth 2020-2025 ($ millions)
Figure 56. Southeast Asia T Cell Specific Surface Glycoprotein CD28 Revenue Growth 2020-2025 ($ millions)
Figure 57. India T Cell Specific Surface Glycoprotein CD28 Revenue Growth 2020-2025 ($ millions)
Figure 58. Australia T Cell Specific Surface Glycoprotein CD28 Revenue Growth 2020-2025 ($ millions)
Figure 59. China Taiwan T Cell Specific Surface Glycoprotein CD28 Revenue Growth 2020-2025 ($ millions)
Figure 60. Europe T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Country in 2025
Figure 61. Europe T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Country (2020-2025)
Figure 62. Europe T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Type (2020-2025)
Figure 63. Europe T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Application (2020-2025)
Figure 64. Germany T Cell Specific Surface Glycoprotein CD28 Revenue Growth 2020-2025 ($ millions)
Figure 65. France T Cell Specific Surface Glycoprotein CD28 Revenue Growth 2020-2025 ($ millions)
Figure 66. UK T Cell Specific Surface Glycoprotein CD28 Revenue Growth 2020-2025 ($ millions)
Figure 67. Italy T Cell Specific Surface Glycoprotein CD28 Revenue Growth 2020-2025 ($ millions)
Figure 68. Russia T Cell Specific Surface Glycoprotein CD28 Revenue Growth 2020-2025 ($ millions)
Figure 69. Middle East & Africa T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Country (2020-2025)
Figure 70. Middle East & Africa T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Type (2020-2025)
Figure 71. Middle East & Africa T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Application (2020-2025)
Figure 72. Egypt T Cell Specific Surface Glycoprotein CD28 Revenue Growth 2020-2025 ($ millions)
Figure 73. South Africa T Cell Specific Surface Glycoprotein CD28 Revenue Growth 2020-2025 ($ millions)
Figure 74. Israel T Cell Specific Surface Glycoprotein CD28 Revenue Growth 2020-2025 ($ millions)
Figure 75. Turkey T Cell Specific Surface Glycoprotein CD28 Revenue Growth 2020-2025 ($ millions)
Figure 76. GCC Countries T Cell Specific Surface Glycoprotein CD28 Revenue Growth 2020-2025 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of T Cell Specific Surface Glycoprotein CD28 in 2025
Figure 78. Manufacturing Process Analysis of T Cell Specific Surface Glycoprotein CD28
Figure 79. Industry Chain Structure of T Cell Specific Surface Glycoprotein CD28
Figure 80. Channels of Distribution
Figure 81. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Forecast by Region (2026-2031)
Figure 82. Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share Forecast by Region (2026-2031)
Figure 83. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share Forecast by Type (2026-2031)
Figure 84. Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share Forecast by Type (2026-2031)
Figure 85. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share Forecast by Application (2026-2031)
Figure 86. Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share Forecast by Application (2026-2031)